With regard to our data, more peripheral CXCR5+CD4+ Tfh cells might be recruited to liver tissues in response to the tumor, ultimately leading to a decrease in circulating CXCR5+CD4+ Tfh cells in HCC patients. This evidence concerns the gene CXCR5 and neoplasm.